Status:
RECRUITING
Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Alberta Health services
Conditions:
Neoplasms
Pediatric Cancer
Eligibility:
All Genders
4-17 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the feasibility and acceptability of a hybrid in-person and virtual individualized physiotherapy program using the Healthy Eating and Active Living (HEAL-ME) ...
Detailed Description
Acute lymphoblastic leukemia is the most common childhood cancer, representing approximately 25% of cancers in children. Improvements in survival rates have resulted in an increased number of children...
Eligibility Criteria
Inclusion
- Children diagnosed with acute lymphoblastic leukemia aged between 4 and 17 years (at time of diagnosis) and their mother, father, or primary carer;
- Undergoing or completed cancer treatment as established by the Children's Oncology Group;
- Access to the internet through a home computer or tablet;
- Patient or caregiver is able to speak and comprehend English; and
- The child is approved by their Oncologist to participate in the program.
Exclusion
- Children with a history of a neurodevelopmental or genetic disorder (i.e., Down syndrome, autism, seizure disorder) prior to the cancer diagnosis; and
- Children with a concurrent condition (illness, disease, psychiatric disorder), as determined by oncologist or physiotherapist, that would compromise study participation or interpretation of study results.
Key Trial Info
Start Date :
April 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06170385
Start Date
April 15 2024
End Date
December 31 2025
Last Update
January 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G2R3